Quantcast

Latest Influenza research Stories

2014-08-28 23:08:03

Transparency Market Research published a new report "U.S. Vaccine Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018" to its report store. Albany, New York (PRWEB) August 28, 2014 Vaccine market - the once low-profit ventured industry is currently perceived with great interest among other healthcare industry sectors and sub-circles in the U.S. This is due to the high demand in vaccine with respect to evolving and spreading infectious diseases. This...

2014-08-18 04:21:18

CYPRESS, Calif. and LONDON, Aug. 18, 2014 /PRNewswire-iReach/ -- Immune Targeting Systems (ITS), specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (Flunisyn(TM)) designed to protect humans from all strains of seasonal and pandemic influenza A. To determine the effectiveness of Flunisyn(TM) ITS produced its own live influenza challenge agent derived from the recently circulating Influenza A/California/2009 (H1N1)...

2014-07-22 08:32:20

- Largest U.S. influenza vaccine supplier, providing broad product portfolio, will distribute at least 65 million doses to help protect people across multiple age groups against the virus this season - SWIFTWATER, Pa., July 22, 2014 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that the first lots of Fluzone(®) (Influenza Vaccine) for the 2014-2015 influenza ("the flu") season have been released by the U.S. Food and Drug...

2014-07-08 12:28:38

MERIDEN, Conn., July 8, 2014 /PRNewswire/ -- Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok. Every year influenza vaccine manufacturers must receive approval from the Agency for changes they make to the upcoming season's manufacturing process and product formulation, as the influenza vaccine is adapted annually. Early approval for Flublok will enable delivery on time to...

2014-06-16 12:29:42

LONDON, June 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Vaccine Partnering Terms and Agreementshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/vaccines/cancer_vaccine_partnering_terms_agreements_1.html The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.Trends in cancer vaccine partnering...

2014-06-16 08:28:43

Cell-culture technology is a modern alternative to manufacture influenza vaccines without chicken eggs, with potential to rapidly respond to a pandemic[1] BASEL, Switzerland, June 16, 2014 /PRNewswire/ -- Novartis today announced that the US Food and Drug Administration (FDA) licensed its manufacturing facility in Holly Springs, N.C. for the production of cell-culture influenza vaccines. This is the first US facility of its kind and is now approved for commercial production. The site will...

2014-05-09 13:32:00

PLOS Certain influenza strains are highly virulent—they cause more serious disease and kill more people. Some of the damage is caused by the stronger immune response such strains elicit, especially in the lung. A study published on May 8th in PLOS Pathogens identifies SOCS4 as a key regulator of the immune response against influenza virus. Lukasz Kedzierski, Sandra Nicholson, and colleagues from the Walter and Eliza Hall Institute of Medical Research and the University of Melbourne,...

2014-04-02 08:34:05

NES ZIONA, Israel, April 2, 2014 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd (TASE: BNDX), developer of a universal flu vaccine, announced today that its Board of Directors has approved initiation of the process for listing the Company's shares for trading in the US through American Depository Receipt (ADR). The Company will act to register an ADR Level 1 Over-The-Counter (OTC), which does not include the option for public offerings in the US (without additional registration)....

Self-administration Of Flu Vaccine With A Patch May Be Possible
2014-02-27 08:47:47

John Toon, Georgia Institute of Technology The annual ritual of visiting a doctor's office or health clinic to receive a flu shot may soon be outdated, thanks to the findings of a new study published in the journal Vaccine. The research, which involved nearly 100 people recruited in the metropolitan Atlanta area, found that test subjects could successfully apply a prototype vaccine patch to themselves. That suggests the self-administration of vaccines with microneedle patches may one...

2014-01-24 11:28:51

Currently approved flu vaccines are less effective in the elderly, yet an estimated 90% of influenza-related deaths occur in people over 65. A paper published on January 23rd in PLOS Pathogens reports on the challenges scientists encountered when they were trying to develop a better flu vaccine. Because immune systems in older people are generally less responsive to vaccination, Jay Evans and colleagues from GlaxoSmithKline Vaccines in Hamilton, USA, were testing so-called...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related